Novavax (NVAX) Reports Q3 Loss of $3.21/sh

Novavax (NASDAQ: NVAX) reported Q3 EPS of ($3.21), versus $0.74 reported last year. Revenue for the quarter came in at $157 million versus the consensus estimate of $230.56 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Evercore lifts Ciena rating on AI-driven optical networking boom
• Credo Technology shares rise on analyst support and conference comments